• No results found

Alzheimer Disease

Optimization of DARTEL Settings for the Detection of Alzheimer Disease

Optimization of DARTEL Settings for the Detection of Alzheimer Disease

... with Alzheimer disease and 198 age-matched healthy subjects; 158 healthy subjects served as the control group against the patients with Alzheimer disease, and the remaining 40 served as the ...

6

Magnetic Resonance Spectroscopy Investigations of Alzheimer Disease

Magnetic Resonance Spectroscopy Investigations of Alzheimer Disease

... Alzheimer disease (AD) is a progressive and neurodegenerative disease of the brain and is the most common cause of ...the disease and their ...this disease will become an even greater ...

198

Tissue segmentation of the brain in Alzheimer disease

Tissue segmentation of the brain in Alzheimer disease

... in Alzheimer patients compared with elderly control ...Since Alzheimer disease is characterized by cortical neuronal loss, it is expected that the percentage of corti- cal gray matter would be ...

9

Prevention of Alzheimer disease. Encouraging evidence.

Prevention of Alzheimer disease. Encouraging evidence.

... hile there are treatments for Alzheimer disease (AD), it is clear that they have sub- stantial limitations, including the inabil- ity to delay progression of disease. It could be that the most effi ...

8

Network abnormalities and interneuron dysfunction in Alzheimer disease.

Network abnormalities and interneuron dysfunction in Alzheimer disease.

... Figure 2 | Encoding reveals network dysfunction in people with mild cognitive impairment. Memory encoding causes specific changes in brain activity-related functional MRI (fMRI) signals across different networks. People ...

17

Alzheimer disease and platelets: how’s that relevant

Alzheimer disease and platelets: how’s that relevant

... Alzheimer Disease (AD) is the most common neurodegenerative disorder worldwide, and account for 60% to 70% of all cases of progressive cognitive impairment in elderly ...

11

Role of EEG for Diagnosis of Alzheimer Disease

Role of EEG for Diagnosis of Alzheimer Disease

... frontal and temporal region in table IV. For AD subjects, the result shows that relative power of delta and theta bands which is slow frequencies band is increased whereas relative power of fast frequencies like alpha ...

5

Cerebrovascular pathology in Down syndrome and Alzheimer disease

Cerebrovascular pathology in Down syndrome and Alzheimer disease

... People with Down syndrome (DS) are at high risk for developing Alzheimer disease (AD) with age. Typically, by age 40 years, most people with DS have sufficient neuropathology for an AD diagnosis. ...

9

Posttranslational modifications of α tubulin in alzheimer disease

Posttranslational modifications of α tubulin in alzheimer disease

... Levels of post-translational modifications of tubulin in the hippocampus, including acetylated tubulin, tyrosinated tubulin, detyrosinated tubulin, and polyglutamylated tubu- lin along with total expression levels of ...

9

Biomarkers in preclinical familial Alzheimer disease

Biomarkers in preclinical familial Alzheimer disease

... Alzheimer disease is often categorized into early onset AD (EOAD), with the debut of clinical symptoms occurring at the age of 65 or younger, and late onset AD (LOAD), when the disease becomes ...

106

Sleep Pattern: Preventing Factors for Alzheimer Disease

Sleep Pattern: Preventing Factors for Alzheimer Disease

... peptide (Aβ) occur in the extracellular space of the brain and get deposited later in the brain. The data revealed by [23] suggested that Aβ aggregation could interrupt the sleep cycle and the fluctuation of Aβ in vivo ...

12

Linear measures of atrophy in mild Alzheimer disease

Linear measures of atrophy in mild Alzheimer disease

... PURPOSE: To assess the sensitivity of linear measures of brain atrophy in the diagnosis of Alzheimer disease (AD) in the early stages. METHODS: Linear measures of regional frontal (bifrontal index, ...

11

Vitamin D and the risk of dementia and Alzheimer disease

Vitamin D and the risk of dementia and Alzheimer disease

... cardiovascular disease, and stroke who participated in the US population–based Cardiovascular Health Study between 1992–1993 and 1999 were ...and Alzheimer disease status were assessed during ...

10

Can naproxen slow the progression of Alzheimer disease?About Alzheimer disease

Can naproxen slow the progression of Alzheimer disease?About Alzheimer disease

... In their study “INTREPAD: A randomized trial of naproxen to slow progress of pre- symptomatic Alzheimer disease,” Dr. Meyer and colleagues 1 studied how naproxen—a common over-the-counter medicine—could ...

5

Molecular Imaging of Alzheimer Disease Pathology

Molecular Imaging of Alzheimer Disease Pathology

... of Alzheimer disease pathology into the ...and Alzheimer disease indicate that ␤-amyloid deposition can be detected many years before the onset of symptoms with molecular imaging, and its ...

6

Salient networks: a novel application to study Alzheimer disease

Salient networks: a novel application to study Alzheimer disease

... performances and the different features extracted from the skeletons prove that sali- ent links underline an information, at least in part, distinct from that obtained with the initial networks. This was also confirmed ...

18

Alzheimer disease & genetics: A mini review

Alzheimer disease & genetics: A mini review

... Alzheimer’s disease (AD) is the most common cause of and with a new case occurring every seven seconds the disease itself is becoming a slow ...of Alzheimer disease with genetic ...of ...

7

BLMH and APOE genes in Alzheimer Disease: A possible relation

BLMH and APOE genes in Alzheimer Disease: A possible relation

... Alzheimer disease (AD) is a progressive and ir- reversible neurodegenerative disorder that is characterized by cognitive decline, memory loss and ...with Alzheimer dis- ease (AD), healthy elderly ...

5

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease

... Alzheimer’s Disease Research Center Cohort in which participants were cognitively normal, had subjective cognitive concerns, or were diagnosed with MCI, worse affective factor score pre- dicted time to progression ...

9

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimer disease pathology and the cerebrospinal fluid proteome

... the disease [8]; on the other hand, subjects with cognitive deficits may present with cognitive impairment suggesting AD but not primarily or only partially related to AD ...prodromal disease stages ...

12

Show all 10000 documents...

Related subjects